Skip to Main Content Menu Search Site

Technologies

We aim to have near-term impact in the world by developing groundbreaking bioinspired technologies, ranging from novel devices and materials to high-value therapeutics and diagnostics, that are translated into commercial products and solutions. If you are interested in any of these technologies, please contact us.

Opportunity Type:

floating garbage on the sea , dirty dump in ocean
Plastivores: Plastic-Degrading Super-Microbes and Enzymes

The Plastic Degradation project identifies microbes from natural sources that have a low-level ability to degrade multiple types of plastic. In the laboratory, with the help of synthetic biology, those microbes then are evolved into much more effective plastic-eating microbes that, in the future, could be globally deployed to decompose plastic waste.

Wearable Technology for True Movement Quantification
Wearable Technology for True Movement Quantification

WurQ combines wearable sensors, with deep learning and signal processing algorithms, to assess the amount, quality, and intensity of functional movements and strength training activities. This quantitative data enables feedback, guidance, and gamification at scale to improve users fitness routines and health.

eRapid: Multiplexed Electrochemical Detection of Complex Diseases
eRapid: Multiplexed Electrochemical Detection of Complex Diseases

StataDX licensed the eRapid portable electrochemical sensing technology to develop diagnostics for neurological, cardiovascular, and renal diseases with a first focus on building a point-of-care platform for difficult-to-detect neurological disorders.

Manufacturing Mini Surgical Robots
Manufacturing Mini Surgical Robots

Project 1985 is commercializing the Wyss Institute’s Pop-Up MEMS technology to quickly and cheaply develop tiny robotic tools for minimally invasive surgery.

CogniXense for Rare Disease Drug Discovery
CogniXense for Rare Disease Drug Discovery

Unravel Biosciences has licensed a Wyss drug discovery platform technology to identify and create drugs to treat complex central nervous system disorders, starting with Rett syndrome.

SPEAR: Ultrasensitive Protein Detection in Small Samples
SPEAR: Ultrasensitive Protein Detection in Small Samples

Spear Bio uses a DNA nanotechnology-driven approach developed at the Wyss Institute that allows the sensitive detection of protein biomarkers in small samples using standard instruments to create new research and diagnostic assays. An ultra-sensitive assay detecting neutralizing antibodies against SARS-CoV-2 will be the first to be commercialized.

View More
Close menu